Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-013033
Filing Date
2019-05-10
Accepted
2019-05-10 16:05:18
Documents
1
Period of Report
2019-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14057
  Complete submission text file 0000899243-19-013033.txt   15356
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Issuer) CIK: 0001596946 (see all company filings)

EIN.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 14 WELLINGTON ROAD NEWTOWN PA 18940
Business Address
Stackawitz Jeremy (Reporting) CIK: 0001604628 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36415 | Film No.: 19814852